| Katherine Deckelbaum, RPH | |
|
17826 Edison Ave, Chesterfield, MO 63005-1262 | |
| (636) 449-8888 | |
| Not Available |
| Full Name | Katherine Deckelbaum |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 17826 Edison Ave, Chesterfield, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184021412 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 2004034217 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Deckelbaum, RPH 17826 Edison Ave, Chesterfield, MO 63005-1262 Ph: () - | Katherine Deckelbaum, RPH 17826 Edison Ave, Chesterfield, MO 63005-1262 Ph: (636) 449-8888 |
News Archive
Gender-sensitized lifestyle programs delivered in professional football clubs have shown promise in increasing physical activity in Europe and could play an important public health role in engaging underserved men, according to a study published February 5 in the open-access journal PLOS Medicine by Sally Wyke of the University of Glasgow, and colleagues.
St. Jude Medical, Inc. today announced U.S. Food and Drug Administration (FDA) approval of its next-generation MultiSteering Technology software for Rapid Programmer™, a programming platform used to optimize neurostimulation therapy for chronic pain patients.
TARIS Biomedical, a specialty pharmaceutical company pioneering the development of innovative, targeted therapies using drug delivery to treat bladder diseases with high unmet medical need, announced that it has initiated a Phase 1B clinical study in patients with interstitial cystitis (IC). The study will evaluate the safety and tolerability of TARIS' innovative product candidate LiRIS® in patients suffering from moderate-to-severe IC.
When published results are systematically tracked for drug trials registered with ClinicalTrials.gov, those from industry-funded trials are the likeliest to be favorable to the drug in question, report researchers at Children's Hospital Boston. Publishing in the August 3 issue of the Annals of Internal Medicine, the researchers call for more public disclosure about clinical drug trials at their outset to reduce the possibility of bias in the findings.
› Verified 2 days ago
Alexander Fred Wood, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14805 N Outer 40 Rd, Chesterfield, MO 63017 Phone: 636-733-7333 | |
Dr. Stephanie R Pieszchalski, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14528 S Outer 40 Rd, Suite 300, Chesterfield, MO 63017 Phone: 314-810-8302 | |
Danielle Christine Chamness, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14805 North Outer 40 Rd Ste 140, Chesterfield, MO 63017 Phone: 636-733-7333 | |
Geizy Momanyi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 917 Chesterfield Pkwy E, Chesterfield, MO 63017 Phone: 636-532-5222 | |
Christina Jeanette Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 739 Goddard Ave, Chesterfield, MO 63005 Phone: 636-534-6800 Fax: 636-534-6797 | |
Edgardo Alvira, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17877 Chesterfield Airport Rd, Chesterfield, MO 63005 Phone: 636-544-2475 | |
Mr. Bradley Schammel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17877 Chesterfield Airport Rd, Chesterfield, MO 63005 Phone: 314-609-5376 |